Your browser doesn't support javascript.
loading
Comparison of PARPi efficacy according to homologous recombination deficiency biomarkers in patients with ovarian cancer: a systematic review and meta-analysis.
Batalini, Felipe; DaSilva, Laercio Lopes; Campoverde, Leticia; Comini, Ana Carolina Marin; Carvalho, Bruno Murad; Nogueira, Wilson; Silveira, Hyan; Ernst, Brenda J; Mina, Lida A.
Affiliation
  • Batalini F; Department of Clinical Oncology, Mayo Clinic Arizona, Phoenix, AZ, USA; Department of Clinical Oncology, Harvard Medical School, Boston, MA, USA.
  • DaSilva LL; Department of Internal Medicine, National Institutes of Health, Bethesda, MD, USA.
  • Campoverde L; Department of Internal Medicine, University of Miami, Miami, FL, USA.
  • Comini ACM; Department of Clinical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Carvalho BM; Faculdade de Medicina de Barbacena, Barbacena, Brazil.
  • Nogueira W; Universidade Estadual do Piauí, Teresina, Brazil.
  • Silveira H; Universidade Federal do Piauí, Parnaíba, Brazil.
  • Ernst BJ; Department of Clinical Oncology, Mayo Clinic Arizona, Phoenix, AZ, USA.
  • Mina LA; Department of Clinical Oncology, Mayo Clinic Arizona, Phoenix, AZ, USA.
Chin Clin Oncol ; 12(3): 21, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37211773
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / BRCA1 Protein Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Language: En Journal: Chin Clin Oncol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / BRCA1 Protein Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Language: En Journal: Chin Clin Oncol Year: 2023 Type: Article Affiliation country: United States